Abstract

Chinese herbal medicine formula Tao Hong Si Wu decoction (THSWD) is traditionally used in China for cerebrovascular diseases. However, the molecular mechanisms of THSWD associated with the cerebral ischemia reperfusion injury are largely unknown. The current study applied the two-dimensional gel electrophoresis-based proteomics to investigate the different protein profiles in PC12 cells with and without the treatment of THSWD. Twenty-six proteins affected by THSWD were identified by MALDI-TOF mass spectrometry. Gene ontology analysis showed that those proteins participated in several important biological processes and exhibited diverse molecular functions. In particular, six of them were found to be phase II antioxidant enzymes, which were regulated by NF-E2-related factor-2 (Nrf2). Quantitative PCR further confirmed a dose-dependent induction of the six phase II enzymes by THSWD at the transcription level. Moreover, the individual ingredients of THSWD were discovered to synergistically contribute to the induction of phase II enzymes. Importantly, THSWD's protection against oxygen-glucose deprivation-reperfusion (OGD-Rep) induced cell death was significantly attenuated by antioxidant response element (ARE) decoy oligonucleotides, suggesting the protection of THSWD may be likely regulated at least in part by Nrf2-mediated phase II enzymes. Thus, our data will help to elucidate the molecular mechanisms underlying the neuroprotective effect of THSWD.

Highlights

  • Traditional Chinese medicinal herbs have been commonly used in China and other Asian countries to combat various diseases for thousands of years

  • We further addressed the question of whether Tao Hong Si Wu decoction (THSWD) could protect against ischemiareperfusion-induced injury

  • To elucidate the molecular mechanisms underlying the protective effect of THSWD on oxygen-glucose deprivation-reperfusion (OGD-Rep), we examined the effect of THSWD on the protein expression in PC12 cells

Read more

Summary

Introduction

Traditional Chinese medicinal herbs have been commonly used in China and other Asian countries to combat various diseases for thousands of years. Combination therapy with individual herbs to form specific formula has been used in TCM for about 2,500 years aiming to increase therapeutic efficacy and reduce adverse effects [5]. Tao Hong Si Wu decoction (THSWD) is a Chinese herbal medicine formula which is traditionally used for the prevention and treatment of cerebrovascular diseases in clinical practice in China. This formula contains six commonly used herbs, including Semen Prunus (Taoren in Chinese, TR), Flos Carthami (Honghua in Chinese, HH), Radix Rehmanniae Preparata (Shengdi in Chinese, SD), Radix Angelicae Sinensis

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call